drugset / Trial / NCT01243307

A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers

NCT01243307

Phase 1 Completed 24 enrolled Creabilis SA Aalborg University Hospital · collab
RandomizedCrossoverQuadruple-blindBasic science

Summary

The primary objective of this study is to compare the effect of CT327 to placebo against experimental induced superficial, deep and hyperalgesic pain. The secondary objectives are to elucidate the mechanisms of CT327 using experimental pain models.

Timeline

Start
2011-01
Primary completion
2011-04
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CT327 Unknown 0.25 g Topical

Indications